We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.13B
AUM Growth
+$281M
Cap. Flow
+$61.6M
Cap. Flow %
1.97%
Top 10 Hldgs %
12.2%
Holding
1,543
New
228
Increased
546
Reduced
510
Closed
166

Top Buys

Rank Stock Value
1
TLOG
TetraLogic Pharmaceuticals Corporation
TLOG
+$8.36M
2
PRF icon
Invesco FTSE RAFI US 1000 ETF
PRF
+$8.14M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$5.91M
4
KMB icon
Kimberly-Clark
KMB
+$5.03M
5
EWU icon
iShares MSCI United Kingdom ETF
EWU
+$3.89M

Top Sells

Rank Stock Value
1
ELD icon
WisdomTree Emerging Markets Local Debt Fund
ELD
+$5.52M
2
BKLN icon
Invesco Senior Loan ETF
BKLN
+$5.39M
3
IXG icon
iShares Global Financials ETF
IXG
+$5.36M
4
CVE icon
Cenovus Energy
CVE
+$5.09M
5
EPP icon
iShares MSCI Pacific ex Japan ETF
EPP
+$4.89M

Sector Composition

Rank Sector Weight
1 Energy 12.37%
2 Healthcare 10.59%
3 Industrials 9.5%
4 Financials 9.49%
5 Technology 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNV
1326
DELISTED
Synovus
SNV
$86K ﹤0.01%
3,429
– –
XRA
1327
DELISTED
Exeter Resources Corporation
XRA
$86K ﹤0.01%
161,125
-67,200
-29% -$43.4K
RITM icon
1328
Rithm Capital
RITM
$5.69B
$84K ﹤0.01%
6,312
-76
-1% -$980
CNSY
1329
Cerenome, Inc. Common Stock
CNSY
$26.4M
– –
0
– –
NVAX icon
1330
Novavax
NVAX
$1.31B
$82K ﹤0.01%
800
– –
GIGM icon
1331
GigaMedia
GIGM
$16.4M
$80K ﹤0.01%
16,022
+11,472
+252% +$57.2K
BTG icon
1332
B2Gold
BTG
$6.64B
$75K ﹤0.01%
37,000
– –
NRO
1333
Neuberger Real Estate Securities Income Fund Inc
NRO
$190M
$75K ﹤0.01%
18,130
+524
+3% +$2.24K
NPTN
1334
DELISTED
NEOPHOTONICS CORP
NPTN
$75K ﹤0.01%
+10,600
New +$70.7K
BAC.WS.B
1335
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$75K ﹤0.01%
97,900
+55,800
+133% +$44.7K
SVBI
1336
DELISTED
Severn Bancorp Inc/MD
SVBI
$71K ﹤0.01%
15,000
– –
COCO
1337
DELISTED
CORINTHIAN COLLEGES INC
COCO
$71K ﹤0.01%
+40,001
New +$77.8K
MJES
1338
DELISTED
MAJESCO HOLDINGS INC. NEW
MJES
$70K ﹤0.01%
118,045
– –
ERNA icon
1339
Eterna Therapeutics
ERNA
$4.91M
– –
0
– –
NSPR icon
1340
InspireMD
NSPR
$34.7M
– –
0
– –
BIOL
1341
DELISTED
Biolase, Inc.
BIOL
$57K ﹤0.01%
+2
New +$47.4K
ESNC
1342
DELISTED
EnSync Inc
ESNC
$55K ﹤0.01%
61,772
+31,962
+107% +$23.8K
AXAS
1343
DELISTED
Abraxas Petroleum Corp
AXAS
$54K ﹤0.01%
825
– –
PRZM
1344
DELISTED
Prism Technologies Group, Inc
PRZM
$50K ﹤0.01%
16,000
– –
AAV
1345
DELISTED
Advantage Oil & Gas Ltd
AAV
$49K ﹤0.01%
11,200
-4,500
-29% -$18.2K
BSDM
1346
DELISTED
BSD MEDICAL CORP (DEL)
BSDM
$48K ﹤0.01%
39,984
– –
TGB
1347
Trekor Metals
TGB
$3.05B
$47K ﹤0.01%
22,000
-13,000
-37% -$27K
MNI
1348
DELISTED
The McClatchy Company Class A Common Stock
MNI
$47K ﹤0.01%
1,370
– –
ALBO
1349
DELISTED
Albireo Pharma Inc
ALBO
$46K ﹤0.01%
667
– –
STAB
1350
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$46K ﹤0.01%
1,975
-382
-16% -$10.4K
52 53
54
55 56

Similar funds

AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Oppenheimer & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Oppenheimer & Co held 1,543 positions worth $3.13B, up 9.9% from $2.84B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co's Q4 2013 filing shows 228 new, 546 increased, 510 reduced and 166 closed positions. Its largest new stake was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M. The largest sale was WisdomTree Emerging Markets Local Debt Fund, an estimated $5.52M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Industrials.

  • Oppenheimer & Co's largest Q4 2013 buy was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M.
  • Oppenheimer & Co added most to Invesco FTSE RAFI US 1000 ETF in Q4 2013, an estimated $8.14M increase.
  • Oppenheimer & Co's biggest Q4 2013 reduction was WisdomTree Emerging Markets Local Debt Fund, cutting an estimated $5.52M.
  • Oppenheimer & Co fully exited iShares Global Financials ETF in Q4 2013, selling an estimated $5.36M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.13B portfolio in Q4 2013.
  • Oppenheimer & Co opened 228 new positions and closed 166 in Q4 2013.
  • Oppenheimer & Co's portfolio value rose 9.9% quarter-over-quarter to $3.13B.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.